CIDP


Also found in: Dictionary, Financial, Acronyms.
Related to CIDP: CIPD

CIDP

polyneuropathy

(pol?e-noo-rop'a-the) [ poly- + neuropathy]
Any disease that affects multiple peripheral nerves.

acute inflammatory demyelinating polyneuropathy

Guillain-Barré syndrome.

acute inflammatory polyneuropathy

Guillain-Barré syndrome.

amyloid polyneuropathy

Polyneuropathy characterized by deposition of amyloid in nerves.

chronic inflammatory demyelinating polyneuropathy

Abbreviation: CIDP
A gradually progressing autoimmune muscle weakness in arms and legs caused by inflammation of the myelin sheath covering peripheral nerve axons. Demyelination slows or blocks conduction of impulses to muscles. Numbness and paresthesia may accompany or precede loss of motor function, which varies from mild to severe. Laboratory findings include elevated protein levels in the cerebrospinal fluid. The inflammatory damage involves not only phagocytes (neutrophils and macrophages), but also immune complexes and complement activation by myelin autoantigens. Immunosuppressive drugs are used to treat this illness. Plasma exchange therapy or infusions of immunoglobulins often are used first, to produce a remission. CIDP is considered to be a chronic counterpart to Guillain-Barré syndrome.

critical illness polyneuropathy

Abbreviation: CIP
A complication occurring in patients in intensive care in which failure to wean from mechanical ventilation is associated with distal limb weakness, loss of distal sensation from light touch or pinprick, and diminished reflexes; facial muscles and nerves are spared. Recovery typically occurs several weeks or months after resolution of the underlying disease. It is associated with the use of drugs, such as corticosteroids or paralytic agents, and neurological illnesses, such as Guillain-Barre syndrome.

diabetic polyneuropathy

Diabetic neuropathy.

familial amyloiditic polyneuropathy

An inherited form of amyloid polyneuropathy in which abnormal forms of transthyretin are deposited in nerves and brain tissue, making multiple nerves malfunction.

paraproteinemic polyneuropathy

Polyneuropathy due to excessive levels of immunoglobulin in the blood. The most commonly implicated immunoglobulins are IgM and IgG.

porphyric polyneuropathy

Polyneuropathy due to acute porphyria, characterized by pains and paresthesias in the extremities and by flaccid paralysis.

progressive hypertrophic polyneuropathy

Déjérine-Sottas disease.

chronic inflammatory demyelinating polyneuropathy

Abbreviation: CIDP
A gradually progressing autoimmune muscle weakness in arms and legs caused by inflammation of the myelin sheath covering peripheral nerve axons. Demyelination slows or blocks conduction of impulses to muscles. Numbness and paresthesia may accompany or precede loss of motor function, which varies from mild to severe. Laboratory findings include elevated protein levels in the cerebrospinal fluid. The inflammatory damage involves not only phagocytes (neutrophils and macrophages), but also immune complexes and complement activation by myelin autoantigens. Immunosuppressive drugs are used to treat this illness. Plasma exchange therapy or infusions of immunoglobulins often are used first, to produce a remission. CIDP is considered to be a chronic counterpart to Guillain-Barré syndrome.
See also: polyneuropathy
References in periodicals archive ?
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
These findings indicated presence of CIDP and patient was treated with Intravenous Methylprednisolone and small volume plasmapheresis.
Electrodiagnostic findings meeting published criteria for, at least, "Possible" CIDP (17) were seen in 41% of "FM Only" subjects, but in no control subjects (p<0.003).
Malik added: "Because nerve damage cannot currently be reversed in diabetic neuropathy it is very important that patients who have CIDP are correctly diagnosed and treated as early as possible so that we limit long-term nerve damage."
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with hypertrophic spinal radiculopathy mimicking neurofibromatosis.
Diagnosis of CIDP is made by a combination of EDX that shows demyelination and lumbar puncture that demonstrates albuminocytologic dissociation.
This report provides comprehensive information on the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Chronic inflammatory demyelinating polyneuropathy (CIDP) and the hypogammaglobulinemia are the leading application for IVIG, collectively contributing about 2/5th of the market revenue
The mechanism of DPN is considered to be mainly axonal apart from diabetic patients with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition that is more frequent in diabetic patients than in the general population.
The 45 patients with non-diabetic peripheral neuropathy were grouped according to the following diagnoses: (1) fifteen patients with segmental demyelination, nine with Guillain-Barre syndrome, five with chronic inflammatory demyelinating poly-radiculo-neuropathy (CIDP), and one with hereditary motor and sensory neuropathy (HMSN), type 1; (2) eleven patients with axonal neuropathy, five with toxic neuropathy, one with vitamin deficiency neuropathy, one with subacute myelo-optico-neuropathy (SMON), two with ischemic neuropathy, and two with amyloid neuropathy; (3) four patients with alcoholic polyneuropathy; and (4) fourteen patients with other poly neuropathy.
Symmetric neuropathies usually present as chronic neuropathies and include distal sensorimotor polyneuropathies; small fibre; autonomic;/large fibre predominant neuropathies and chronic inflammatory demyelinating polyradiculopathies (CIDP).
Walgreens utilized its PartnerPoint Clinical Management platform--a single-solution, interactive clinical system--to capture reported outcomes for patients receiving home IG for either chronic inflammatory demyelinating polyneuropathy (CIDP) or myositis.